[go: up one dir, main page]

ID30039A - NEW BEADS OF CONTROL PHARMACEUTICAL CONTROL PHARMACEUTICAL METHODS AND THE FORMULATION OF VARIOUS UNITS CONTAINING IT - Google Patents

NEW BEADS OF CONTROL PHARMACEUTICAL CONTROL PHARMACEUTICAL METHODS AND THE FORMULATION OF VARIOUS UNITS CONTAINING IT

Info

Publication number
ID30039A
ID30039A IDW00200101038A ID20011038A ID30039A ID 30039 A ID30039 A ID 30039A ID W00200101038 A IDW00200101038 A ID W00200101038A ID 20011038 A ID20011038 A ID 20011038A ID 30039 A ID30039 A ID 30039A
Authority
ID
Indonesia
Prior art keywords
control pharmaceutical
formulation
various units
units containing
control
Prior art date
Application number
IDW00200101038A
Other languages
Indonesian (id)
Inventor
Torkel Gren
Anders Ringberg
Martin Wikberg
Randy J Wald
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30039(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of ID30039A publication Critical patent/ID30039A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW00200101038A 1998-11-11 1999-11-11 NEW BEADS OF CONTROL PHARMACEUTICAL CONTROL PHARMACEUTICAL METHODS AND THE FORMULATION OF VARIOUS UNITS CONTAINING IT ID30039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (en) 1998-11-11 1998-11-11 Therapeutic method and formulation

Publications (1)

Publication Number Publication Date
ID30039A true ID30039A (en) 2001-11-01

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101038A ID30039A (en) 1998-11-11 1999-11-11 NEW BEADS OF CONTROL PHARMACEUTICAL CONTROL PHARMACEUTICAL METHODS AND THE FORMULATION OF VARIOUS UNITS CONTAINING IT

Country Status (40)

Country Link
US (1) US6911217B1 (en)
EP (1) EP1128819B1 (en)
JP (1) JP3616011B2 (en)
KR (1) KR100467384B1 (en)
CN (1) CN1169522C (en)
AP (1) AP1323A (en)
AR (1) AR027815A1 (en)
AT (1) ATE247458T1 (en)
AU (1) AU762410B2 (en)
BG (1) BG65149B1 (en)
BR (1) BRPI9915142B8 (en)
CA (1) CA2350061C (en)
CZ (1) CZ299582B6 (en)
DE (1) DE69910604T2 (en)
DK (1) DK1128819T3 (en)
EA (1) EA005074B1 (en)
EE (1) EE05232B1 (en)
ES (1) ES2204193T3 (en)
GE (1) GEP20022833B (en)
HK (1) HK1040917B (en)
HR (1) HRP20010333B1 (en)
HU (1) HU226582B1 (en)
ID (1) ID30039A (en)
IL (1) IL142809A0 (en)
IS (1) IS2370B (en)
MA (1) MA25325A1 (en)
MY (1) MY122195A (en)
NO (1) NO331399B1 (en)
NZ (1) NZ511430A (en)
OA (1) OA11673A (en)
PL (1) PL195780B1 (en)
PT (1) PT1128819E (en)
RS (1) RS49891B (en)
SE (1) SE9803871D0 (en)
SI (1) SI1128819T1 (en)
SK (1) SK284758B6 (en)
TW (2) TWI267385B (en)
UA (1) UA57165C2 (en)
WO (1) WO2000027364A1 (en)
ZA (1) ZA200103575B (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310103B1 (en) * 1996-07-19 2001-10-30 Bridge Pharma, Inc. S(−)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
KR20070091374A (en) 1999-11-11 2007-09-10 화이자 헬스 에이비 Pharmaceutical formulations comprising tolterodine and uses thereof
EP1536780A1 (en) * 2002-08-28 2005-06-08 Pharmacia Corporation Oral liquid tolterodine composition
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
KR20050096147A (en) * 2003-01-22 2005-10-05 피저 헬스 에이비 Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
DE10315917A1 (en) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
JP4771956B2 (en) 2003-11-04 2011-09-14 スパーナス ファーマシューティカルズ インコーポレイテッド Composition of a quaternary ammonium compound containing a bioavailability enhancer
PT2210605T (en) 2003-11-04 2017-04-24 Tcd Royalty Sub Llc Once daily dosage forms of trospium
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) † 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
WO2006074479A1 (en) * 2005-01-10 2006-07-13 Teva Pharmaceutical Industries, Ltd. Process for preparing tolterodine tartrate
ES2607988T3 (en) 2005-05-31 2017-04-05 Iams Europe B.V. Feline probiotic bifidobacteria
EP2270131A1 (en) 2005-05-31 2011-01-05 The Iams Company Feline probiotic lactobacilli
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
HUE027282T2 (en) 2006-01-18 2016-11-28 Intec Pharma Ltd Method for forming delivery devices for oral intake of an agent
WO2007092755A2 (en) 2006-02-03 2007-08-16 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
KR100714058B1 (en) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 Sustained release oral composition of tolterodine L-tartrate and preparation method thereof
JP2009527554A (en) * 2006-02-24 2009-07-30 テバ ファーマシューティカル インダストリーズ リミティド Metoprolol succinate R. Tablet and preparation method thereof
EP1996169A2 (en) * 2006-03-21 2008-12-03 Teva Pharmaceutical Industries Ltd Controlled release formulation of tolterodine
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
CN104825397A (en) * 2006-04-03 2015-08-12 伊萨·奥迪迪 Controlled Release Delivery Devices Containing Organosol Coatings
US20070248670A1 (en) * 2006-04-21 2007-10-25 Van Den Heuvel Dennie J M Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2026766A1 (en) 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
PL2037936T3 (en) 2006-06-21 2015-04-30 Opko Renal Llc Method of treating and preventing secondary hyperparathyroidism
JP2008007458A (en) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd Core particle for layering and method for producing the same
UA99448C2 (en) 2006-11-27 2012-08-27 Х. Луннбэк А/С Heteroaryl amide derivatives
CN101711158A (en) 2007-02-01 2010-05-19 爱默思公司 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
JP5501956B2 (en) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド Controlled release oral composition containing a vitamin D compound and a waxy carrier
JP5444212B2 (en) 2007-04-25 2014-03-19 シトクロマ インコーポレイテッド Method for treating vitamin D deficiency and deficiency
WO2009003724A1 (en) * 2007-07-03 2009-01-08 Synthon B.V. Tolterodine bead
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
EP2175843B1 (en) * 2007-08-08 2014-10-08 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
CN105534936B (en) 2007-08-13 2020-07-31 Ohemo 生命科学股份有限公司 Abuse resistant drugs, methods of use and methods of preparation
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
EP3112476B1 (en) 2008-04-02 2023-08-02 EirGen Pharma Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
US20090311317A1 (en) * 2008-05-14 2009-12-17 Capricorn Pharma Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CA2769760A1 (en) * 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
KR102125424B1 (en) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 Methods and compositions for reducing parathyroid levels
JO3112B1 (en) 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
NZ619857A (en) 2010-03-29 2015-05-29 Ferring Bv A fast dissolving pharmaceutical composition
EP2563123B1 (en) 2010-04-30 2018-04-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
WO2012154770A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (en) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
CA2848785A1 (en) 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition
WO2013047795A1 (en) * 2011-09-30 2013-04-04 アステラス製薬株式会社 Granular pharmaceutical composition
JP6259454B2 (en) 2012-07-12 2018-01-10 フェリング ベスローテン フェンノートシャップ Diclofenac formulation
JP2015529255A (en) * 2012-09-20 2015-10-05 オーエイチアール ファーマ， エルエルシーＯｈｒ Ｐｈａｒｍａ， Ｌｌｃ Multilayer biodegradable microparticles for sustained release of therapeutic agents
TW201422254A (en) 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
WO2014159051A1 (en) * 2013-03-13 2014-10-02 Advanced Bionutrition Corp. Stable bioactive substances and methods of making
US10420726B2 (en) 2013-03-15 2019-09-24 Inspirion Delivery Sciences, Llc Abuse deterrent compositions and methods of use
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA2936748C (en) * 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20190083628A1 (en) * 2016-02-23 2019-03-21 Nipro Corporation Pharmaceutical composition particles and orally disintegrating preparation including the same
JP7032322B2 (en) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド Vitamin D treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (en) * 1981-03-19 1986-10-29 Pharmatec Spa CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN
JPH07107450A (en) 1993-10-08 1995-04-21 Hitachi Ltd Information communication equipment
JP3453186B2 (en) 1994-04-14 2003-10-06 共和薬品工業株式会社 Sustained-release microcapsules and method for producing the same
SE9402422D0 (en) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US6310103B1 (en) 1996-07-19 2001-10-30 Bridge Pharma, Inc. S(−)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
SE9803871D0 (en) 1998-11-11
WO2000027364A1 (en) 2000-05-18
UA57165C2 (en) 2003-06-16
BG105582A (en) 2001-12-29
HU226582B1 (en) 2009-04-28
GEP20022833B (en) 2002-11-25
HRP20010333B1 (en) 2004-10-31
KR20010075695A (en) 2001-08-09
EE200100254A (en) 2002-12-16
JP2003517446A (en) 2003-05-27
ATE247458T1 (en) 2003-09-15
SK284758B6 (en) 2005-11-03
HRP20010333A2 (en) 2003-04-30
EP1128819B1 (en) 2003-08-20
BRPI9915142B8 (en) 2021-05-25
NO20012314L (en) 2001-07-09
AU762410B2 (en) 2003-06-26
YU33101A (en) 2003-10-31
DE69910604T2 (en) 2004-06-24
EA005074B1 (en) 2004-10-28
AR027815A1 (en) 2003-04-16
BG65149B1 (en) 2007-04-30
KR100467384B1 (en) 2005-01-24
TWI267385B (en) 2006-12-01
SK6252001A3 (en) 2002-01-07
AP2001002166A0 (en) 2001-06-30
HUP0105038A3 (en) 2006-07-28
IL142809A0 (en) 2002-03-10
IS5936A (en) 2001-05-09
ES2204193T3 (en) 2004-04-16
CZ299582B6 (en) 2008-09-10
OA11673A (en) 2005-01-12
CN1169522C (en) 2004-10-06
MA25325A1 (en) 2001-12-31
EA200100538A1 (en) 2001-10-22
US6911217B1 (en) 2005-06-28
NZ511430A (en) 2003-05-30
MY122195A (en) 2006-03-31
CA2350061C (en) 2005-05-17
HK1040917A1 (en) 2002-06-28
SI1128819T1 (en) 2003-12-31
JP3616011B2 (en) 2005-02-02
IS2370B (en) 2008-06-15
EE05232B1 (en) 2009-12-15
BRPI9915142B1 (en) 2015-08-25
NO20012314D0 (en) 2001-05-10
TWI222879B (en) 2004-11-01
CN1326339A (en) 2001-12-12
RS49891B (en) 2008-08-07
ZA200103575B (en) 2002-05-03
EP1128819A1 (en) 2001-09-05
CA2350061A1 (en) 2000-05-18
DK1128819T3 (en) 2003-12-01
HUP0105038A2 (en) 2002-06-29
CZ20011627A3 (en) 2001-10-17
AP1323A (en) 2004-11-05
PT1128819E (en) 2003-12-31
NO331399B1 (en) 2011-12-19
PL348612A1 (en) 2002-06-03
HK1040917B (en) 2005-05-27
BR9915142A (en) 2001-08-07
PL195780B1 (en) 2007-10-31
DE69910604D1 (en) 2003-09-25
AU1436600A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
ID30039A (en) NEW BEADS OF CONTROL PHARMACEUTICAL CONTROL PHARMACEUTICAL METHODS AND THE FORMULATION OF VARIOUS UNITS CONTAINING IT
ID18320A (en) NEW MEDICINE PRODUCTS AND USES OF IT
ID22426A (en) NEW KETOBENZAMIDA AND ITS USE
ID21806A (en) FORM OF PHARMACEUTICAL QUARTERING THAT WAS QUICKLY REMOVED AND THAT COVERED
DE69834972D1 (en) Plasma display panel and manufacturing method of the same
ID23439A (en) 3-PIPERIDYL-4-OXSOKUINAZOLIN DECREASES AND THE SAME PHARMACY COMPOSITIONS
ID22490A (en) BENZAMIDES SUBSTITUTED BY NEW HETEROSICLIC AND ITS USE
ID29843A (en) DRUG GIVING SYSTEM THROUGH THE REGULAR CONTROL OF THE MOUTH WHICH PROVIDES CONTROL AND TEMPORARY ACTIVITIES
ID26248A (en) NEW ASIGUANIDINE DECREASED AS BONE ABSORPTION INHIBITOR AND AS VITRONECTTIN RECEPTOR ANTAGONISTS
ID19479A (en) NEW AMIDINO DECREASES AND USE AS TROMBIN OBSTACLES
ID25469A (en) STORIES OF CHRISTALOGRAPHY AND THE PROCESS OF MAKING AMORF SEFALOSPORINE
NO984094L (en) Discharge reactor and use of the same
ID27558A (en) NEW AROMATIC AMIDES, THE METHOD OF MAKING IT AND USING IT AS A MEDICINE
NO971811D0 (en) Bicyclic tetrahydropyrazolopyridines and their use as drugs
HUP0000189A3 (en) Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use
ID20604A (en) SYNTHETIC POLICAKARIDA PROCESS FOR THE MAKING AND COMPOSITION OF THE PHARMACY CONTAINED
ID22283A (en) NEW THERAPY COMBINATIONS OF MIRTAZAPIN AND ANTIPSICOTIC SUBSTANCES FOR TREATMENT OR PROPILACTIC PSYCHOTIC DISORDERS
ID24259A (en) DRUG FORMULATION THAT HAS CONTROL OF ACTIVATED COMPOUNDS
ID22911A (en) NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT
ID18682A (en) ASILTRANSFERASE AND PLASMA THAT encode ASILTRANSFERASE
ID24716A (en) NEW FORMULATION
ID17199A (en) MICRO-ORGANISM OF THE HYDROCARBON DECREASE OF HALOGEN AND ITS USE
DE69420178D1 (en) Liquid application device and manufacture of the same
ID19050A (en) NEW CARBOXICATE ACID DRIVINGS, ITS MANUFACTURE AND USE OF IT
ID21289A (en) METHOD OF THE ADHESIVE AND EQUIPMENT OF ITS